Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 4 Grant or award President & COO acquired 9,069 shares (grant or award)
  2. 4 Grant or award See Remarks acquired 5,668 shares (grant or award)
  3. 4 Grant or award Chief Executive Officer acquired 17,005 shares (grant or award)
  4. 8-K Event Results of operations
  5. 4 Shares withheld for taxes President & COO gave up 2,890 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 849 shares (to pay taxes)
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13D/A Stake Beneficial Ownership Report
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 4 Other acquisition Chief Financial Officer acquired 275 shares (other)
  15. 4 Shares withheld for taxes President & COO gave up 3,859 shares (to pay taxes)
  16. 4 Shares withheld for taxes Director gave up 5,289 shares (to pay taxes)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 18 of 115 · 2,300 filings